Featured
Pfizer Obesity Drug Pipeline Shows Promise in Late-Stage Trials
Pfizer's oral obesity drug showed promise in late-stage trials, matching injectable competitors. A daily pill could disrupt the GLP-1 market by offeri...
Read Full Story →Recent Articles
BusinessPfizer Announces 5% Dividend Increase
Pfizer Inc. announced a 5% increase in its quarterly dividend on June 17, 2026, rewarding shareholde...